or Try an Advanced Search...

    Technical Analysis for ADMA - ADMA Biologics Inc

    Grade Last Price % Change Price Change
    A 20.29 3.68% 0.72
    ADMA closed up 3.68 percent on Friday, October 4, 2024, on 82 percent of normal volume. The bulls were able to push the stock to a new 52-week high.
    7 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Up
    Historical ADMA trend table...
    Date Alert Name Type % Chg
    New 52 Week Closing High Bullish 0.00%
    New 52 Week High Strength 0.00%
    Multiple of Ten Bullish Other 0.00%
    Gapped Up Strength 0.00%
    Overbought Stochastic Strength 4.05%
    Gapped Down Weakness 4.05%
    Multiple of Ten Bearish Other 2.63%
    Inside Day Range Contraction 2.63%
    Overbought Stochastic Strength 2.63%
    New 52 Week High Strength 1.50%
    Older End-of-Day Signals for ADMA ...

       Recent Intraday Alerts

    Alert Time
    New 52 Week High about 17 hours ago
    Up 5% about 17 hours ago
    Up 1 ATR about 17 hours ago
    60 Minute Opening Range Breakout about 17 hours ago
    Rose Above Previous Day's High about 22 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    ADMA Chart by TradingView
    Basic chart:

    Profile

    ADMA Biologics, Inc., a late stage biopharmaceutical company, develops, manufactures, and intends to market plasma-based biologics for the treatment and prevention of infectious diseases. Its lead product candidate, RI-002, which is in Phase III clinical trial, is intended for the treatment of primary immune deficiency disease. RI-002 is an injectable immune globulin derived from human plasma enriched with high levels of naturally occurring polyclonal antibodies, as well as high levels of antibodies targeted to respiratory syncytial virus. The company also operates ADMA BioCenters, which are plasma collection centers. ADMA Biologics, Inc. was founded in 2004 and is headquartered in Ramsey, New Jersey.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biotechnology Biopharmaceutical Biology Immunology Immune System Infectious Diseases Antibodies Antibody Glycoproteins Polyclonal Antibodies

    Is ADMA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 2 Are Medical Stocks Lagging ADMA Biologics (ADMA) This Year?
    Oct 2 ADMA Biologics: Riding High On ASCENIV's Success
    Sep 30 Adma Biologics (ADMA) Is a Great Choice for 'Trend' Investors, Here's Why
    Sep 27 Biotech Hangs On To Top Spot On This List, And It Even Outshines Nvidia
    Sep 27 ABBV's Newly Added Parkinson's Disease Drug Meets Second Study Goal
    Sep 26 Is ADMA Biologics Inc. (ADMA) the Best Performing Small-Cap Stock in 2024?
    Sep 26 Adma Biologics (ADMA) Stock Sinks As Market Gains: Here's Why
    Sep 26 Pfizer Withdraws Sickle Cell Disease Therapy Oxbryta From Market
    Sep 23 Millennium Management LLC Acquires Shares in ADMA Biologics Inc
    Sep 20 Adma Biologics (ADMA) Gains As Market Dips: What You Should Know
    See more ADMA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 20.58
    52 Week Low 3.06
    Average Volume 5,210,598
    200-Day Moving Average 9.85
    50-Day Moving Average 16.94
    20-Day Moving Average 19.05
    10-Day Moving Average 19.68
    Average True Range 0.83
    RSI (14) 66.33
    ADX 38.76
    +DI 30.96
    -DI 11.38
    Chandelier Exit (Long, 3 ATRs) 18.10
    Chandelier Exit (Short, 3 ATRs) 18.55
    Upper Bollinger Bands 20.96
    Lower Bollinger Band 17.15
    Percent B (%b) 0.83
    BandWidth 20.00
    MACD Line 0.84
    MACD Signal Line 0.90
    MACD Histogram -0.0565
    Fundamentals Value
    Market Cap 4.58 Billion
    Num Shares 226 Million
    EPS -0.11
    Price-to-Earnings (P/E) Ratio -184.45
    Price-to-Sales 5.05
    Price-to-Book 7.81
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 21.60
    Resistance 3 (R3) 21.55 21.06 21.38
    Resistance 2 (R2) 21.06 20.73 21.09 21.30
    Resistance 1 (R1) 20.68 20.53 20.87 20.73 21.23
    Pivot Point 20.19 20.19 20.29 20.22 20.19
    Support 1 (S1) 19.81 19.86 20.00 19.86 19.35
    Support 2 (S2) 19.32 19.66 19.35 19.28
    Support 3 (S3) 18.94 19.32 19.20
    Support 4 (S4) 18.99